HomeARSUF • OTCMKTS
add
Fagron NV
Previous close
$18.59
Year range
$16.15 - $19.26
Market cap
1.31B EUR
Avg Volume
353.00
P/E ratio
-
Dividend yield
-
Primary exchange
EBR
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | 195.71M | 10.16% |
Operating expense | 57.27M | 8.96% |
Net income | 18.76M | 8.90% |
Net profit margin | 9.58 | -1.14% |
Earnings per share | — | — |
EBITDA | 30.96M | 19.86% |
Effective tax rate | 10.65% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 137.28M | 9.13% |
Total assets | 1.01B | 3.70% |
Total liabilities | 539.33M | -3.78% |
Total equity | 467.63M | — |
Shares outstanding | 72.99M | — |
Price to book | 2.93 | — |
Return on assets | 6.85% | — |
Return on capital | 8.26% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | 18.76M | 8.90% |
Cash from operations | 40.68M | 14.80% |
Cash from investing | -9.12M | 4.92% |
Cash from financing | -20.87M | -12.89% |
Net change in cash | 10.40M | 83.36% |
Free cash flow | 16.80M | 10.63% |
About
Fagron NV is a publicly traded multinational group of companies governed by Belgian law. Its registered office is located in Waregem, Belgium, and its headquarters is located at Rotterdam, Netherlands. Founded as Arseus NV, it was formerly the Professional Health Division of Omega Pharma, and became an independent entity via an IPO on October 5, 2007 and has been listed on Euronext Brussels and Euronext Amsterdam since then. Its share is included in the BEL MID-index and the Amsterdam Small Cap Index. The head office of Fagron is located in Rotterdam. Wikipedia
Founded
1990
Website
Employees
3,282
